Development of antibody engineering-based cancer therapies

$1,761,905ZIAFY2024CANIH

Division Of Basic Sciences - Nci

Investigators

Mitchell Hocontact

Linked publications & trials

Paper 39043602 Paper 38740967 Paper 38227666 Paper 38036617 Paper 37910044 Paper 37031249 Paper 36997331 Paper 36691969 Paper 36640111 Paper 36631162 Paper 36594750 Paper 35512094 Paper 35499461 Paper 35317524 Paper 35312769 Paper 35157290 Paper 35157288 Paper 34725191 Paper 34195677 Paper 33992682 Paper 33833049 Paper 33664415 Paper 33420124 Paper 32671329 Paper 32623934 Paper 32575752 Paper 32566896 Paper 32432544 Paper 32166218 Paper 32060001 Paper 31520528 Paper 30963603 Paper 30353932 Paper 30352677 Paper 30294716 Paper 30091851 Paper 28739923 Paper 28165915 Paper 27669301 Paper 27419635 Paper 27185050 Paper 26332121 Paper 25996440 Paper 25758784 Paper 24492943 Paper 24260587 Paper 24140348 Paper 23471984 Paper 23371858 Paper 23145926 Paper 22864478 Paper 22820551 Paper 22737246 Paper 22721387 Paper 22563565 Paper 22043235 Paper 21942912 Paper 21611109 Paper 21479131 Paper 21305058 Paper 21112773 Paper 20967331 Paper 20922056 Paper 20673133 Paper 20635390 Paper 20617511 Paper 20103626 Paper 19554290 Paper 19417159 Paper 19252855 Paper 19252852 Paper 19075018

View original record on NIH RePORTER →